Literature DB >> 19946977

Rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis.

Luis R Espinoza1.   

Abstract

Entities:  

Year:  2009        PMID： 19946977     DOI： 10.1007/s11926-009-0068-3

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


× No keyword cloud information.
  9 in total

Review 1.  Evidence-based management of ANCA vasculitis.

Authors:  David Carruthers; Jonathan Sherlock
Journal:  Best Pract Res Clin Rheumatol       Date:  2009-06       Impact factor: 4.098

2.  Evolving concepts in pathogenesis and treatment of ANCA-associated systemic vasculitides.

Authors:  Cees G M Kallenberg; Ming-Hui Zhao
Journal:  Nephrology (Carlton)       Date:  2009-02       Impact factor: 2.506

3.  Mycophenolate mofetil in anti-neutrophil cytoplasm antibodies-associated systemic vasculitis.

Authors:  Maria Koukoulaki; David R W Jayne
Journal:  Nephron Clin Pract       Date:  2005-11-10

4.  Relapsed Wegener's granulomatosis after rituximab therapy--B cells are present in new pathological lesions despite persistent 'depletion' of peripheral blood.

Authors:  Alastair J Ferraro; Stuart W Smith; Desley Neil; Caroline O S Savage
Journal:  Nephrol Dial Transplant       Date:  2008-06-27       Impact factor: 5.992

5.  Biologic therapy in primary systemic vasculitis of the young.

Authors:  Despina Eleftheriou; Marianna Melo; Stephen D Marks; Kjell Tullus; John Sills; Gavin Cleary; Pavla Dolezalova; Seza Ozen; Clarissa Pilkington; Pat Woo; Nigel Klein; Michael J Dillon; Paul A Brogan
Journal:  Rheumatology (Oxford)       Date:  2009-06-17       Impact factor: 7.580

6.  Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.

Authors:  Kirsten de Groot; Lorraine Harper; David R W Jayne; Luis Felipe Flores Suarez; Gina Gregorini; Wolfgang L Gross; Rashid Luqmani; Charles D Pusey; Niels Rasmussen; Renato A Sinico; Vladimir Tesar; Philippe Vanhille; Kerstin Westman; Caroline O S Savage
Journal:  Ann Intern Med       Date:  2009-05-19       Impact factor: 25.391

Review 7.  Newer therapies for vasculitis.

Authors:  Thomas F Hiemstra; David Jayne
Journal:  Best Pract Res Clin Rheumatol       Date:  2009-06       Impact factor: 4.098

8.  Adjunction of rituximab to steroids and immunosuppressants for refractory/relapsing Wegener's granulomatosis: a study on 8 patients.

Authors:  B Brihaye; A Aouba; C Pagnoux; P Cohen; F Lacassin; L Guillevin
Journal:  Clin Exp Rheumatol       Date:  2007 Jan-Feb       Impact factor: 4.473

9.  Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: an open-label extension analysis.

Authors:  Edward Keystone; Roy Fleischmann; Paul Emery; Daniel E Furst; Ronald van Vollenhoven; Joan Bathon; Maxime Dougados; Andrew Baldassare; Gianfranco Ferraccioli; Andrew Chubick; James Udell; Matthew W Cravets; Sunil Agarwal; Simon Cooper; Fabio Magrini
Journal:  Arthritis Rheum       Date:  2007-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.